Innovacell Inc.

504A TSE Pharmaceuticals Pharmaceutical
TSE Growth
¥543.00
-3.38%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of -9.08.
  • Return on equity is healthy at 150.2%.
  • Current assets comfortably cover current liabilities (current ratio 10.4).

!Watch-points

  • Thin interest cover: operating profit covers interest only about -2.6 times.
  • Return on capital employed is on the lower side at -47.9%.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
-2.79

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

Piotroski F-ScoreWeak
3 / 4

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 4 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap¥245億
Current Price¥ 543.00
High / Low¥ 1,248.00 / 377.00
Stock P/E-6.10
Book Value¥ -78.95
Dividend Yield0%
ROCE-47.89%
ROE150.16%
Debt to Equity-9.08
Current Ratio10.40
P/B Ratio2.5691736
EPS¥ -89.00
ICR-2.60
Educational data only. Not a recommendation to buy, sell or hold any security.